When Context Is Hard to Come By: External Comparators and How to Use Them
Overview
Pharmacology
Affiliations
External comparators, also referred to as historical or synthetic controls, present transformational opportunities for broad context and insights alongside clinical research results. The recent confluence of access to quality real-world data (RWD), advanced epidemiologic methods, and legislative directives to regulators for expanded use of RWD is increasing interest in real-world external comparators, opening the door to achieve broader generalizability and learn more, faster. In this less standardized area of research, tailored scientific methodology must be applied for external comparators to accomplish clinical development objectives. Here, we describe methodological considerations for design and illustrate how RWD comparators have been used for regulatory and reimbursement decisions.
Rippin G, Sanz H, Hoogendoorn W, Ballarini N, Largent J, Demas E Drug Saf. 2024; 47(12):1245-1263.
PMID: 39102176 PMC: 11554740. DOI: 10.1007/s40264-024-01467-9.
A Review of Causal Inference for External Comparator Arm Studies.
Rippin G, Ballarini N, Sanz H, Largent J, Quinten C, Pignatti F Drug Saf. 2022; 45(8):815-837.
PMID: 35895225 DOI: 10.1007/s40264-022-01206-y.
Wood W, Marks P, Plovnick R, Hewitt K, Neuberg D, Walters S Blood Adv. 2021; 5(23):5429-5438.
PMID: 34673922 PMC: 9153041. DOI: 10.1182/bloodadvances.2021005902.
Seeger J, Davis K, Iannacone M, Zhou W, Dreyer N, Winterstein A Pharmacoepidemiol Drug Saf. 2020; 29(11):1382-1392.
PMID: 32964514 PMC: 7756307. DOI: 10.1002/pds.5141.